Free Trial

Apogee Therapeutics (APGE) Competitors

Apogee Therapeutics logo
$36.62 -1.17 (-3.10%)
Closing price 04:00 PM Eastern
Extended Trading
$36.63 +0.01 (+0.03%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APGE vs. RVMD, RYTM, RNA, NUVL, AXSM, CRSP, ABVX, MRUS, CYTK, and VKTX

Should you be buying Apogee Therapeutics stock or one of its competitors? The main competitors of Apogee Therapeutics include Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), Avidity Biosciences (RNA), Nuvalent (NUVL), Axsome Therapeutics (AXSM), CRISPR Therapeutics (CRSP), Abivax (ABVX), Merus (MRUS), Cytokinetics (CYTK), and Viking Therapeutics (VKTX). These companies are all part of the "pharmaceutical products" industry.

Apogee Therapeutics vs. Its Competitors

Revolution Medicines (NASDAQ:RVMD) and Apogee Therapeutics (NASDAQ:APGE) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Revolution Medicines presently has a consensus target price of $69.92, indicating a potential upside of 82.42%. Apogee Therapeutics has a consensus target price of $97.29, indicating a potential upside of 165.66%. Given Apogee Therapeutics' higher possible upside, analysts clearly believe Apogee Therapeutics is more favorable than Revolution Medicines.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revolution Medicines
0 Sell rating(s)
0 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
3.00
Apogee Therapeutics
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

Apogee Therapeutics has lower revenue, but higher earnings than Revolution Medicines. Apogee Therapeutics is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution Medicines$11.58M618.74-$600.09M-$4.50-8.52
Apogee TherapeuticsN/AN/A-$182.15M-$4.13-8.87

In the previous week, Revolution Medicines had 2 more articles in the media than Apogee Therapeutics. MarketBeat recorded 7 mentions for Revolution Medicines and 5 mentions for Apogee Therapeutics. Apogee Therapeutics' average media sentiment score of 1.79 beat Revolution Medicines' score of 1.33 indicating that Apogee Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revolution Medicines
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Apogee Therapeutics
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

94.3% of Revolution Medicines shares are held by institutional investors. Comparatively, 79.0% of Apogee Therapeutics shares are held by institutional investors. 8.2% of Revolution Medicines shares are held by company insiders. Comparatively, 42.8% of Apogee Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Revolution Medicines has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Apogee Therapeutics has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500.

Apogee Therapeutics' return on equity of -34.65% beat Revolution Medicines' return on equity.

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A -41.78% -35.63%
Apogee Therapeutics N/A -34.65%-32.76%

Summary

Apogee Therapeutics beats Revolution Medicines on 8 of the 14 factors compared between the two stocks.

Get Apogee Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APGE vs. The Competition

MetricApogee TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.69B$3.06B$5.76B$9.84B
Dividend YieldN/A2.26%3.95%4.02%
P/E Ratio-8.8721.2231.3126.60
Price / SalesN/A390.30461.30121.37
Price / CashN/A44.4437.7659.36
Price / Book2.738.0710.026.67
Net Income-$182.15M-$54.08M$3.27B$265.59M
7 Day Performance0.74%2.26%3.17%3.42%
1 Month Performance-7.67%3.42%4.34%1.09%
1 Year Performance-24.39%18.61%44.11%23.85%

Apogee Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APGE
Apogee Therapeutics
3.7671 of 5 stars
$36.62
-3.1%
$97.29
+165.7%
-20.5%$1.69BN/A-8.8791Positive News
Analyst Forecast
RVMD
Revolution Medicines
4.318 of 5 stars
$36.45
+0.4%
$69.54
+90.8%
-12.7%$6.79B$11.58M-8.10250News Coverage
Positive News
RYTM
Rhythm Pharmaceuticals
3.5242 of 5 stars
$98.09
+0.5%
$101.57
+3.5%
+115.7%$6.48B$130.13M-32.59140Positive News
Insider Trade
RNA
Avidity Biosciences
2.9852 of 5 stars
$44.48
-4.3%
$67.00
+50.6%
+9.4%$5.98B$10.90M-12.49190Positive News
NUVL
Nuvalent
3.439 of 5 stars
$75.01
-1.4%
$119.60
+59.4%
-9.7%$5.48BN/A-15.3140News Coverage
Positive News
AXSM
Axsome Therapeutics
4.7772 of 5 stars
$111.13
+1.8%
$178.00
+60.2%
+37.0%$5.45B$385.69M-21.92380News Coverage
Positive News
Insider Trade
CRSP
CRISPR Therapeutics
3.5205 of 5 stars
$57.59
-3.6%
$71.60
+24.3%
+11.0%$5.43B$37.31M-10.61460Positive News
Analyst Upgrade
ABVX
Abivax
2.7265 of 5 stars
$70.01
-0.6%
$92.33
+31.9%
+564.1%$5.32BN/A0.0061News Coverage
Positive News
Analyst Revision
MRUS
Merus
2.3278 of 5 stars
$66.00
-1.9%
$88.50
+34.1%
+26.9%$5.09B$56.23M-12.0037News Coverage
Positive News
Analyst Forecast
CYTK
Cytokinetics
3.7387 of 5 stars
$38.95
+0.7%
$71.58
+83.8%
-32.3%$4.63B$18.47M-7.64250News Coverage
Positive News
VKTX
Viking Therapeutics
3.8982 of 5 stars
$42.09
+5.1%
$86.92
+106.5%
-56.7%$4.50BN/A-27.5120

Related Companies and Tools


This page (NASDAQ:APGE) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners